These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

686 related items for PubMed ID: 27249092

  • 21. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA.
    JAMA; 2007 Apr 18; 297(15):1683-96. PubMed ID: 17440145
    [Abstract] [Full Text] [Related]

  • 22. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.
    Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctôt KL.
    J Clin Psychiatry; 2010 Mar 18; 71(3):270-9. PubMed ID: 20122371
    [Abstract] [Full Text] [Related]

  • 23. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G, Beeské S, Stahl SM.
    J Clin Psychiatry; 2012 Nov 18; 73(11):1403-11. PubMed ID: 23146246
    [Abstract] [Full Text] [Related]

  • 24. Does the frequency of follow-up assessments affect clinical trial outcome? A meta-analysis and meta-regression of placebo-controlled randomized trials.
    Iovieno N, Tedeschini E, Levkovitz Y, Ameral VE, Papakostas GI.
    Int J Neuropsychopharmacol; 2012 Apr 18; 15(3):289-96. PubMed ID: 21557881
    [Abstract] [Full Text] [Related]

  • 25. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun 18; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 26. Double-blind, placebo-controlled trial of pioglitazone for bipolar depression.
    Aftab A, Kemp DE, Ganocy SJ, Schinagle M, Conroy C, Brownrigg B, D'Arcangelo N, Goto T, Woods N, Serrano MB, Han H, Calabrese JR, Gao K.
    J Affect Disord; 2019 Feb 15; 245():957-964. PubMed ID: 30699881
    [Abstract] [Full Text] [Related]

  • 27. Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy: a meta-analysis.
    Pedrelli P, Iovieno N, Vitali M, Tedeschini E, Bentley KH, Papakostas GI.
    J Clin Psychopharmacol; 2011 Oct 15; 31(5):582-6. PubMed ID: 21869696
    [Abstract] [Full Text] [Related]

  • 28. Relationship between placebo response rate and clinical trial outcome in bipolar depression.
    Iovieno N, Nierenberg AA, Parkin SR, Hyung Kim DJ, Walker RS, Fava M, Papakostas GI.
    J Psychiatr Res; 2016 Mar 15; 74():38-44. PubMed ID: 26736040
    [Abstract] [Full Text] [Related]

  • 29. Bipolar depression: a new role for atypical antipsychotics?
    Keck PE.
    Bipolar Disord; 2005 Mar 15; 7 Suppl 4():34-40. PubMed ID: 15948765
    [Abstract] [Full Text] [Related]

  • 30. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression.
    Goldberg JF, Burdick KE, Endick CJ.
    Am J Psychiatry; 2004 Mar 15; 161(3):564-6. PubMed ID: 14992985
    [Abstract] [Full Text] [Related]

  • 31. Meta-analysis of placebo rates in major depressive disorder trials.
    Stolk P, Ten Berg MJ, Hemels ME, Einarson TR.
    Ann Pharmacother; 2003 Dec 15; 37(12):1891-9. PubMed ID: 14632596
    [Abstract] [Full Text] [Related]

  • 32. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.
    Eur Neuropsychopharmacol; 2008 Jul 15; 18(7):535-49. PubMed ID: 18501566
    [Abstract] [Full Text] [Related]

  • 33. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS, Benazzi F, Perugi G, Rihmer Z.
    J Affect Disord; 2005 Apr 15; 85(3):245-58. PubMed ID: 15780694
    [Abstract] [Full Text] [Related]

  • 34. Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials.
    Sinyor M, Schaffer A, Smart KA, Levitt AJ, Lanctôt KL, Grysman NH.
    J Clin Psychiatry; 2012 Feb 15; 73(2):e277-87. PubMed ID: 22401489
    [Abstract] [Full Text] [Related]

  • 35. N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials.
    Kishi T, Miyake N, Okuya M, Sakuma K, Iwata N.
    Psychopharmacology (Berl); 2020 Nov 15; 237(11):3481-3487. PubMed ID: 32767039
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
    Weisler RH, Montgomery SA, Earley WR, Szamosi J, Lazarus A.
    Int Clin Psychopharmacol; 2012 Jan 15; 27(1):27-39. PubMed ID: 22027845
    [Abstract] [Full Text] [Related]

  • 37. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
    Mocking RJ, Harmsen I, Assies J, Koeter MW, Ruhé HG, Schene AH.
    Transl Psychiatry; 2016 Mar 15; 6(3):e756. PubMed ID: 26978738
    [Abstract] [Full Text] [Related]

  • 38. Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials.
    Maslej MM, Furukawa TA, Cipriani A, Andrews PW, Sanches M, Tomlinson A, Volkmann C, McCutcheon RA, Howes O, Guo X, Mulsant BH.
    JAMA Psychiatry; 2021 May 01; 78(5):490-497. PubMed ID: 33595620
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
    Cruz N, Sanchez-Moreno J, Torres F, Goikolea JM, Valentí M, Vieta E.
    Int J Neuropsychopharmacol; 2010 Feb 01; 13(1):5-14. PubMed ID: 19638254
    [Abstract] [Full Text] [Related]

  • 40. Recent placebo-controlled acute trials in bipolar depression: focus on methodology.
    Muzina DJ, Calabrese JR.
    Int J Neuropsychopharmacol; 2003 Sep 01; 6(3):285-91. PubMed ID: 12974995
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.